Evidence map›Paper›PMID 35811452›Full record

ArticleJournal of medical virology2022

Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.

Nilgun Duman, Gulten Tuncel, Atil Bisgin, Sevcan Tug Bozdogan, Sebnem Ozemri Sag, Seref Gul, Aslihan Kiraz, Burhan Balta, Murat Erdogan, Bulent Uyanik and 17 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Association of specificFrontiers in immunology · 2024
    Article
  3. Review
  4. Article
  5. Corrigendum.Journal of medical virology · 2023
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 16 institutions in 2 countries.

Nilgun DumanDepartment of Medical Genetics, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Gulten TuncelDESAM Research Institute, Near East University, Nicosia, Cyprus.
Atil BisginDepartment of Medical Genetics, Faculty of Medicine, Çukurova University, Adana, Turkey.
Sevcan Tug BozdoganDepartment of Medical Genetics, Faculty of Medicine, Çukurova University, Adana, Turkey.
Sebnem Ozemri SagDepartment of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Seref GulDepartment of Biology, Biotechnology Division, Faculty of Sciences, Istanbul University, Istanbul, Turkey.
Aslihan KirazDepartment of Medical Genetics, Kayseri Education and Research State Hospital, Kayseri, Turkey.
Burhan BaltaDepartment of Medical Genetics, Kayseri Education and Research State Hospital, Kayseri, Turkey.
Murat ErdoganDepartment of Medical Genetics, Kayseri Education and Research State Hospital, Kayseri, Turkey.
Bulent UyanikDepartment of Medical Genetics, Istanbul Bakırkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
Sezin CanbekDepartment of Medical Genetics, Umraniye City Hospital, Istanbul, Turkey.
Pinar AtaDepartment of Medical Genetics, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Bilgen Bilge GeckinliDepartment of Medical Genetics, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Esra Arslan AtesDepartment of Medical Genetics, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Ceren AlavandaDepartment of Medical Genetics, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Sevda Yesim OzdemirDepartment of Medical Genetics, Faculty of Medicine, Uskudar University, İstanbul, Turkey.
Ozlem SezerDepartment of Medical Genetics, Samsun Education and Research Hospital, Samsun, Turkey.
Gulay Oner OzgonNesiller Genetic Diagnosis Center, Istanbul, Turkey.
Hakan GurkanDepartment of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Kubra GulerMikrogen Genetic Diagnostic Center, Ankara, Turkey.
Ibrahim BogaDepartment of Medical Genetics, Faculty of Medicine, Çukurova University, Adana, Turkey.
Niyazi KayaDepartment of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Adem AlemdarDepartment of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Murat SayanDESAM Research Institute, Near East University, Nicosia, Cyprus.
Munis DundarDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Mahmut Cerkez ErgorenDESAM Research Institute, Near East University, Nicosia, Cyprus.
Sehime Gulsun TemelDepartment of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.ORCID 0000-0002-9802-0880
Bursa Uludağ Üni̇versi̇tesi̇ · TRMarmara University · TRCukurova University · TRKayseri Eğitim ve Araştırma Hastanesi · TRNear East University · CYBakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi · TRBezmiâlem Vakıf Üniversitesi · TRErciyes University · TRHaliç University · TRIntergen (Turkey) · TRIstanbul University · TRKocaeli Üniversitesi · TRSamsun University · TRTrakya University · TRÜmraniye Eğitim ve Araştırma Hastanesi · TRÜsküdar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneity in symptoms associated with COVID-19 in infected patients remains unclear. ACE2 and TMPRSS2 gene variants are considered possible risk factors for COVID-19. In this study, a retrospective comparative genome analysis of the ACE2 and TMPRSS2 variants from 946 whole-exome sequencing data was conducted. Allele frequencies of all variants were calculated and filtered to remove variants with allele frequencies lower than 0.003 and to prioritize functional coding variants. The majority of detected variants were intronic, only two ACE2 and three TMPRSS2 nonsynonymous variants were detected in the analyzed cohort. The main ACE2 variants that putatively have a protective or susceptibility effect on SARS-CoV-2 have not yet been determined in the Turkish population. The Turkish genetic makeup likely lacks any ACE2 variant that increases susceptibility to SARS-CoV-2 infection. TMPRSS2 rs75603675 and rs12329760 variants that were previously defined as common variants that have different allele frequencies among populations and may have a role in SARS-CoV-2 attachment to host cells were determined in the population. Overall, these data will contribute to the formation of a national variation database and may also contribute to further studies of ACE2 and TMPRSS2 in the Turkish population and differences in SARS-CoV-2 infection among other populations.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2Exome SequencingHumansPeptidyl-Dipeptidase ARetrospective StudiesRisk FactorsSerine EndopeptidasesACE2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase ASerine EndopeptidasesTMPRSS2 protein, humanACE2COVID-19SARS-CoV-2TMPRSS2variant

Identifiers

PMID35811452
PMCPMC9349697
OpenAlexW4285009180

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.